Exelixis Inc
(NAS:EXEL)
$
36.115
0.265 (0.74%)
Market Cap: 10.31 Bil
Enterprise Value: 9.21 Bil
PE Ratio: 23.15
PB Ratio: 4.54
GF Score: 91/100 Exelixis Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) Transcript
Feb 09, 2022 / 06:30PM GMT
Release Date Price:
$19.38
(+2.11%)
Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst & Senior MD
All right. Hello, and welcome. My name is Michael Schmidt. I'm a senior biotech analyst with Guggenheim Securities, and it's my great pleasure to welcome Michael Morrissey, President and CEO of Exelixis. Welcome, Michael, and thanks for joining us again this year.
Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director
Great to see you again virtually. Looking forward to doing this live, hopefully, next year.
Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst & Senior MD
Yes, we'll be ready.
Questions & Answers
Michael Werner Schmidt
Guggenheim Securities, LLC, Research Division - Senior Analyst & Senior MD
So looking forward to it as well. So Michael, let's just jump right into questions and skip over the slide presentation. Cabo, as you all know, has generated over $1 billion in net sales in 2021 and
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot